Stryker price target raised to $348 from $345 at Roth MKM

Roth MKM raised the firm’s price target on Stryker to $348 from $345 and keeps a Buy rating on the shares. The firm is raising its FY24 EPS view by 15c to $12.00 after the company’s Q4 results, with organic revenue up 11%, the analyst tells investors in a research note. Roth MKM adds that consensus estimates on Stryker remain “too low”.